학술논문
Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha–Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer Models
Document Type
Article
Author
Source
In: Neoplasia (United States) . (Neoplasia (United States), 2016, 18(12):775-784)
Subject
Language
English
ISSN
14765586
15228002
15228002